Zhitong Finance App News, Kehua Biotech (002022.SZ) issued an announcement. Recently, the company and its holding subsidiary Suzhou Tianlong Biotechnology Co., Ltd. (hereinafter referred to as “Suzhou Tianlong”) received a medical device registration certificate (in vitro diagnostic reagent) issued by the State Drug Administration. Drugs involved: “Chlamydia trachomatis nucleic acid detection kit (PCR-fluorescence method)” and “parainfluenza virus nucleic acid detection kit (fluorescence PCR method)”.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.